Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival
- PMID: 26168069
- PMCID: PMC5343753
- DOI: 10.1038/bmt.2015.162
Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival
Abstract
Although hemorrhagic cystitis (HC) is a common complication of allogeneic hematopoietic cell transplantation (alloHCT), its risk factors and effects on survival are not well known. We evaluated HC in a large cohort (n=1321, 2003-2012) receiving alloHCT from all graft sources, including umbilical cord blood (UCB). We compared HC patients with non-HC (control) patients and examined clinical variables at HC onset and resolution. Of these 1321 patients, 219 (16.6%) developed HC at a median of 22 days after alloHCT. BK viruria was detected in 90% of 109 tested HC patients. Median duration of HC was 27 days. At the time of HC diagnosis, acute GVHD, fever, severe thrombocytopenia and steroid use were more frequent than at the time of HC resolution. In univariate analysis, male sex, age <20 years, myeloablative conditioning with cyclophosphamide and acute GVHD were associated with HC. In multivariate analysis, HC was significantly more common in males and HLA-mismatched UCB graft recipients. Severe grade HC (grade III-IV) was associated with increased treatment-related mortality but not with overall survival at 1 year. HC remains hazardous and therefore better prophylaxis, and early interventions to limit its severity are still needed.
Conflict of interest statement
No Conflict of Interest to disclose
Figures
Similar articles
-
Incidence and risk factor of hemorrhagic cystitis after allogeneic transplantation with fludarabine, busulfan, and anti-thymocyte globulin myeloablative conditioning.Transpl Infect Dis. 2017 Jun;19(3). doi: 10.1111/tid.12677. Epub 2017 Apr 17. Transpl Infect Dis. 2017. PMID: 28199755
-
Hemorrhagic cystitis following hematopoietic stem cell transplantation: incidence, risk factors and association with CMV reactivation and graft-versus-host disease.Chin Med J (Engl). 2007 Oct 5;120(19):1666-71. Chin Med J (Engl). 2007. PMID: 17935666
-
The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD.Bone Marrow Transplant. 2014 Dec;49(12):1528-34. doi: 10.1038/bmt.2014.181. Epub 2014 Aug 11. Bone Marrow Transplant. 2014. PMID: 25111517
-
Risk factors for BK virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.Clin Transplant. 2023 Nov;37(11):e15121. doi: 10.1111/ctr.15121. Epub 2023 Sep 7. Clin Transplant. 2023. PMID: 37676427 Review.
-
Male predominance among Japanese adult patients with late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation.Bone Marrow Transplant. 2003 Dec;32(12):1175-9. doi: 10.1038/sj.bmt.1704274. Bone Marrow Transplant. 2003. PMID: 14647272 Review.
Cited by
-
The effect of myeloablative radiation on urinary bladder mast cells.Sci Rep. 2024 Mar 14;14(1):6219. doi: 10.1038/s41598-024-56655-5. Sci Rep. 2024. PMID: 38485999 Free PMC article.
-
Human Leukocyte Antigen-Haploidentical Haematopoietic Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for Paediatric Haematological Malignancies.Cancers (Basel). 2024 Jan 31;16(3):600. doi: 10.3390/cancers16030600. Cancers (Basel). 2024. PMID: 38339351 Free PMC article. Review.
-
Long-Term Follow-Up after Adoptive Transfer of BK-Virus-Specific T Cells in Hematopoietic Stem Cell Transplant Recipients.Vaccines (Basel). 2023 Apr 14;11(4):845. doi: 10.3390/vaccines11040845. Vaccines (Basel). 2023. PMID: 37112757 Free PMC article.
-
Heinz body hemolysis following extended use phenazopyridine in a post-HCT patient with hemorrhagic cystitis: An old problem for a new generation.Clin Case Rep. 2023 Mar 7;11(3):e7012. doi: 10.1002/ccr3.7012. eCollection 2023 Mar. Clin Case Rep. 2023. PMID: 36911643 Free PMC article.
-
CMV infection is a risk factor for hemorrhagic cystitis after hematopoietic stem cell transplantation.Ann Hematol. 2023 May;102(5):1193-1201. doi: 10.1007/s00277-023-05121-9. Epub 2023 Feb 8. Ann Hematol. 2023. PMID: 36752843
References
-
- Silva LD, Patah PA, Saliba RM, Szewczyk NA, Gilman L, Neumann J, et al. Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplants Is the Complex Result of Bk Virus Infection, Preparative Regimen Intensity and Donor Type. Haematologica-the Hematology Journal. 2010;95(7):1183–1190. - PMC - PubMed
-
- Ilhan O, Koc H, Akan H, Gurman G, Arslan O, Ozcan M, et al. Hemorrhagic Cystitis as a Complication of Bone Marrow Transplantation. J Chemother. 1997;9(1):56–61. - PubMed
-
- Cesaro S, Brugiolo A, Faraci M, Uderzo C, Rondelli R, Favre C, et al. Incidence and Treatment of Hemorrhagic Cystitis in Children Given Hematopoietic Stem Cell Transplantation: A Survey from the Italian Association of Pediatric Hematology Oncology-Bone Marrow Transplantation Group. Bone Marrow Transplant. 2003;32(9):925–931. - PubMed
-
- Mori Y, Miyamoto T, Kamezaki K, Kato K, Kikushige Y, Takashima S, et al. Low Incidence of Adenovirus Hemorrhagic Cystitis Following Autologous Hematopoietic Stem Cell Transplantation in the Rituximab Era. Am J Hematol. 2012;87(8):828–830. - PubMed
-
- Fioriti D, Degener AM, Mischitelli M, Videtta M, Arancio A, Sica S, et al. Bkv Infection and Hemorrhagic Cystitis after Allogeneic Bone Marrow Transplant. Int J Immunopathol Pharmacol. 2005;18(2):309–316. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials